Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Carisma Therapeutics Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 51 | 53 | +2 |
| Shares | 8.51M | 6.11M | −2.40M (−28.2%) |
| Value | $19.3M | $9.28M | −$10.0M (−51.9%) |
New holders (22)
Institutions that held Carisma Therapeutics Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 232,793 | $353.8K | 0.00% |
| Millennium Management LLC | 160,041 | $243.3K | 0.00% |
| Jane Street Group, LLC | 159,879 | $243.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 75,501 | $114.8K | 0.01% |
| Susquehanna International Group, LLP | 73,323 | $111.5K | 0.00% |
| Centiva Capital, LP | 54,500 | $82.8K | 0.00% |
| Qube Research & Technologies Ltd | 31,652 | $48.1K | 0.00% |
| Paloma Partners Management Co | 31,578 | $48.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 26,006 | $39.5K | 0.01% |
| Wexford Capital LP | 19,861 | $30.2K | 0.01% |
| Mirae Asset Global ETFs Holdings Ltd. | 13,016 | $19.8K | 0.00% |
| Clear Street Markets LLC | 5,210 | $8.00K | 0.00% |
| Catalyst Funds Management Pty Ltd | 3,900 | $5.93K | 0.00% |
| Federated Hermes, Inc. | 3,312 | $5.03K | 0.00% |
| Point72 (DIFC) Ltd | 1,996 | $3.04K | 0.00% |
| Macquarie Group Ltd | 1,373 | $2.09K | 0.00% |
| Russell Investments Group, Ltd. | 645 | $980 | 0.00% |
| Bank & Trust Co | 525 | $798 | 0.00% |
| ORG Partners LLC | 200 | $334 | 0.00% |
| Harbour Investments, Inc. | 37 | $56 | 0.00% |
| Nisa Investment Advisors, LLC | 20 | $30 | 0.00% |
| McMahon Financial Advisors, LLC | 8 | $12 | 0.00% |
Sold out (20)
Institutions that held Carisma Therapeutics Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 102,702 | $233.1K |
| Bank of New York Mellon Corp | 77,712 | $176.4K |
| Charles Schwab Investment Management Inc | 60,952 | $138.4K |
| Two Sigma Investments, LP | 40,602 | $92.2K |
| Arrowstreet Capital, Limited Partnership | 40,605 | $92.0K |
| Invesco Ltd. | 40,409 | $91.7K |
| Citadel Advisors LLC | 38,973 | $88.5K |
| Wells Fargo & Company | 19,371 | $44.0K |
| CIBC Asset Management Inc | 14,971 | $34.0K |
| American International Group, Inc. | 13,140 | $29.8K |
| Connor, Clark & Lunn Investment Management Ltd. | 13,043 | $29.6K |
| XTX Topco Ltd | 12,540 | $28.5K |
| Deutsche Bank AG | 12,267 | $27.8K |
| Occudo Quantitative Strategies LP | 10,120 | $23.0K |
| California State Teachers Retirement System | 2,680 | $6.08K |
| Ameritas Investment Partners, Inc. | 2,202 | $5.00K |
| Legal & General Group Plc | 2,156 | $4.89K |
| Amalgamated Bank | 899 | $2.00K |
| Ancora Advisors, LLC | 65 | $148 |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 5 | $11 |